Vaccination and immunization management skill. Tracks vaccine history, schedules future doses, provides regional vaccination recommendations, and prepares travel immunization plans. Triggers on: vaccine, vaccination, immunization, shots, flu shot, travel vaccines, vaccine schedule, booster, immunization record.
Comprehensive vaccination management skill that tracks your immunization history, schedules upcoming doses, and provides personalized vaccine recommendations for your location and travel plans.
| Vaccine | Schedule | Indication |
|---|---|---|
| Influenza | Annual | All adults |
| Tdap/Td | Tdap once, Td every 10 years | All adults |
| COVID-19 | Per current guidance | All adults |
| Hepatitis B | 2-3 doses | Adults 19-59 |
| HPV | 2-3 doses if not completed | Through age 26; 27-45 discuss |
| Shingles | 2 doses (Shingrix) | 50+ years |
| Pneumococcal | 1-2 doses | 65+ or risk conditions |
| MMR | 1-2 doses if not immune | Adults without evidence |
| Varicella | 2 doses if not immune | Adults without evidence |
| Population | Additional Vaccines |
|---|---|
| Healthcare workers | Hep B, MMR, Varicella, Flu annually |
| Travelers | Hep A, Typhoid, Yellow fever (region dependent) |
| Pregnant | Tdap each pregnancy, Flu annually |
| Immunocompromised | Avoid live vaccines |
| Vaccine | Destinations | Schedule |
|---|---|---|
| Hepatitis A | Most countries | 2 doses, 6 months apart |
| Hepatitis B | Endemic regions | 2-3 doses |
| Typhoid | Developing countries | 1 dose (IM) or 4 doses (oral) |
| Yellow fever | Africa, South America | 1 dose, valid for life |
| Japanese Encephalitis | Rural Asia | 2 doses |
| Rabies | High-risk areas | 3 doses pre-exposure |
| Meningococcal | Sub-Saharan Africa, Hajj | 1-2 doses |
{
"vaccination_history": [
{
"vaccine": "Influenza",
"date": "2025-10-15",
"type": "Quadrivalent",
"provider": "CVS Pharmacy",
"next_due": "2026-10-01"
},
{
"vaccine": "COVID-19",
"date": "2025-09-20",
"type": "Pfizer Bivalent",
"provider": "Health Clinic",
"next_due": "Per guidance"
},
{
"vaccine": "Shingrix",
"dose": 1,
"date": "2026-03-01",
"next_due": "2026-05-01"
}
],
"immune_status": {
"mmr": "immune (childhood)",
"varicella": "history of disease",
"hep_b": "vaccinated (childhood)"
}
}
# Vaccination Report — March 20, 2026
## ✅ Up to Date
| Vaccine | Last Dose | Next Due | Status |
|---------|-----------|----------|--------|
| Influenza | Oct 15, 2025 | Oct 2026 | ✅ Current |
| COVID-19 | Sep 20, 2025 | Per guidance | ✅ Current |
| Tdap | Aug 2015 | Aug 2025 | ✅ Current (10-year) |
| Hepatitis B | Childhood | Lifetime | ✅ Immune |
| MMR | Childhood | Lifetime | ✅ Immune |
---
## ⏳ Pending / In Progress
| Vaccine | Status | Next Action | Due Date |
|---------|--------|-------------|----------|
| Shingrix | Dose 1 done | Schedule dose 2 | May 1, 2026 |
---
## ⚠️ Due Soon
| Vaccine | Due Date | Action |
|---------|----------|--------|
| Influenza | Oct 2026 | Schedule fall vaccination |
---
## 🌍 Travel Vaccination Assessment
### Planned Trip: Thailand (June 2026)
**Recommended**:
- ✅ Hepatitis A (2-dose series — start now)
- ✅ Hepatitis B (if not immune)
- ✅ Typhoid (oral or injectable)
- ✅ Japanese Encephalitis (rural areas >1 month)
- ✅ Routine vaccines (ensure current)
**Required**:
- None for Thailand (unless coming from yellow fever area)
**Timeline**:
- **Now**: Start Hep A series
- **April**: Complete Hep A dose 2, get Typhoid
- **May**: Japanese Encephalitis (if needed)
- **June**: Travel
---
## 📋 Recommendations
### This Month
- [ ] Schedule Shingrix dose 2 (due May 1)
### Next 3 Months
- [ ] Start Hepatitis A series for Thailand trip
- [ ] Review travel vaccine needs with provider
### Annual
- [ ] Influenza vaccine (Oct 2026)
---
## 📊 Vaccination Summary
| Category | Count | Status |
|----------|-------|--------|
| Routine Adult | 5/5 | ✅ Complete |
| Age-Appropriate | 1/2 | ⏳ In progress |
| Travel-Specific | 0/3 (planned) | 📋 Planning |
---
⚠️ **Note**: Vaccination recommendations vary by country and individual health status. Consult your healthcare provider for personalized advice.
**Last Updated**: March 20, 2026